Literature DB >> 11447020

Impaired biliary lipid secretion in obese Zucker rats: leptin promotes hepatic cholesterol clearance.

S VanPatten1, N Ranginani, S Shefer, L B Nguyen, L Rossetti, D E Cohen.   

Abstract

Human obesity is associated with elevated plasma leptin levels. Obesity is also an important risk factor for cholesterol gallstones, which form as a result of cholesterol hypersecretion into bile. Because leptin levels are correlated with gallstone prevalence, we explored the effects of acute leptin administration on biliary cholesterol secretion using lean (FA/-) and obese (fa/fa) Zucker rats. Zucker (fa/fa) rats become obese and hyperleptinemic due to homozygosity for a missense mutation in the leptin receptor, which diminishes but does not completely eliminate responsiveness to leptin. Rats were infused intravenously for 12 h with saline or pharmacological doses of recombinant murine leptin (5 microg x kg(-1) x min(-1)) sufficient to elevate plasma leptin concentrations to 500 ng/ml compared with basal levels of 3 and 70 ng/ml in lean and obese rats, respectively. Obesity was associated with a marked impairment in biliary cholesterol secretion. In biles of obese compared with lean rats, bile salt hydrophobicity was decreased whereas phosphatidylcholine hydrophobicity was increased. High-dose leptin partially normalized cholesterol secretion in obese rats without altering lipid compositions, implying that both chronic effects of obesity and relative resistance to leptin contributed to impaired biliary cholesterol elimination. In lean rats, acute leptin administration increased biliary cholesterol secretion rates. Without affecting hepatic cholesterol contents, leptin downregulated hepatic activity of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, upregulated activities of both sterol 27-hydroxylase and cholesterol 7alpha-hydroxylase, and lowered plasma very low-density lipoprotein cholesterol concentrations. Increased biliary cholesterol secretion in the setting of decreased cholesterol biosynthesis and increased catabolism to bile salts suggests that leptin promotes elimination of plasma cholesterol.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11447020     DOI: 10.1152/ajpgi.2001.281.2.G393

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  24 in total

1.  Intracerebroventricular leptin regulates hepatic cholesterol metabolism.

Authors:  Sonya Vanpatten; George B Karkanias; Luciano Rossetti; David E Cohen
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

2.  Intermittent ischaemia maintains function after ischaemia reperfusion in steatotic livers.

Authors:  Mathilde Steenks; Mark C P M van Baal; Vincent B Nieuwenhuijs; Menno T de Bruijn; Marc Schiesser; Mike H Teo; Tom Callahan; Rob T A Padbury; Greg J Barritt
Journal:  HPB (Oxford)       Date:  2010-05       Impact factor: 3.647

3.  Attenuated Effects of Bile Acids on Glucose Metabolism and Insulin Sensitivity in a Male Mouse Model of Prenatal Undernutrition.

Authors:  Huijuan Ma; Vicencia M Sales; Ashley R Wolf; Sathish Subramanian; Tucker J Matthews; Michael Chen; Aparna Sharma; Walt Gall; Wim Kulik; David E Cohen; Yusuke Adachi; Nicholas W Griffin; Jeffrey I Gordon; Mary-Elizabeth Patti; Elvira Isganaitis
Journal:  Endocrinology       Date:  2017-08-01       Impact factor: 4.736

4.  Evidence that leptin contributes to intestinal cholesterol absorption in obese (ob/ob) mice and wild-type mice.

Authors:  M Igel; B Lindenthal; U Giesa; Bergmann K von
Journal:  Lipids       Date:  2002-02       Impact factor: 1.880

5.  Serum leptin levels and insulin resistance are associated with gallstone disease in overweight subjects.

Authors:  Nahum Méndez-Sánchez; Luisa-B Bermejo-Martínez; Yolanda Viñals; Norberto-C Chavez-Tapia; Irina Vander Graff; Guadalupe Ponciano-Rodríguez; Martha-H Ramos; Misael Uribe
Journal:  World J Gastroenterol       Date:  2005-10-21       Impact factor: 5.742

6.  Hepatic nuclear corepressor 1 regulates cholesterol absorption through a TRβ1-governed pathway.

Authors:  Inna Astapova; Preeti Ramadoss; Ricardo H Costa-e-Sousa; Felix Ye; Kaila A Holtz; Yingxia Li; Michele W Niepel; David E Cohen; Anthony N Hollenberg
Journal:  J Clin Invest       Date:  2014-04-08       Impact factor: 14.808

7.  The 223A>G polymorphism of the leptin receptor gene and lipid-lowering efficacy of simvastatin in Chinese patients with coronary heart disease.

Authors:  Yan-Ming Sun; Lan-Feng Wang; Jia Li; Zhu-Qin Li; Wei Pan
Journal:  Eur J Clin Pharmacol       Date:  2008-10-16       Impact factor: 2.953

8.  Cholesterol feeding of mice expressing cholesterol 7alpha-hydroxylase increases bile acid pool size despite decreased enzyme activity.

Authors:  Michaela Tiemann; Zhihua Han; Raymond Soccio; Jaya Bollineni; Sarah Shefer; Ephraim Sehayek; Jan L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-04       Impact factor: 11.205

9.  Sensitivity of lipid metabolism and insulin signaling to genetic alterations in hepatic peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression.

Authors:  Jennifer L Estall; Mario Kahn; Marcus P Cooper; Ffolliott Martin Fisher; Michele K Wu; Dina Laznik; Lishu Qu; David E Cohen; Gerald I Shulman; Bruce M Spiegelman
Journal:  Diabetes       Date:  2009-04-14       Impact factor: 9.461

10.  Progressive obesity leads to altered ovarian gene expression in the Lethal Yellow mouse: a microarray study.

Authors:  John Brannian; Kathleen Eyster; Mandi Greenway; Cody Henriksen; Kim Teslaa; Maureen Diggins
Journal:  J Ovarian Res       Date:  2009-08-03       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.